• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病和银屑病关节炎的治疗:一种跨学科方法。

The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.

作者信息

Gordon Kenneth B, Ruderman Eric M

机构信息

Division of Dermatology, Evanston Northwestern Healthcare, Skokie, Illinois 60077, USA.

出版信息

J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S85-91. doi: 10.1016/j.jaad.2005.10.052.

DOI:10.1016/j.jaad.2005.10.052
PMID:16488334
Abstract

Psoriatic arthritis is a common inflammatory arthritis associated with psoriasis, occurring in 5% to 40% of patients with cutaneous disease. Recently, there has been an increased appreciation of the need to use an integrated approach to these 2 diseases, considering both entities when determining therapeutic choices. In this review, the available therapeutic options for psoriatic arthritis are considered, along with the potential benefit that these medications may have for cutaneous psoriasis. Finally, a conceptual model for the therapy of psoriasis and psoriatic arthritis, the Four Quadrant Model, is presented as a simplified framework to use when considering treatment for psoriatic disease.

摘要

银屑病关节炎是一种与银屑病相关的常见炎性关节炎,见于5%至40%的皮肤病患者。最近,人们越来越认识到需要对这两种疾病采用综合方法,在确定治疗选择时要同时考虑这两种情况。在本综述中,我们考虑了银屑病关节炎可用的治疗选择,以及这些药物对皮肤银屑病可能具有的潜在益处。最后,提出了一种银屑病和银屑病关节炎治疗的概念模型——四象限模型,作为在考虑银屑病治疗时使用的简化框架。

相似文献

1
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.银屑病和银屑病关节炎的治疗:一种跨学科方法。
J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S85-91. doi: 10.1016/j.jaad.2005.10.052.
2
Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.抗肿瘤坏死因子α疗法在银屑病关节炎和银屑病中的应用。
Arch Dermatol. 2001 Jun;137(6):784-5.
3
TNFalpha therapy in psoriatic arthritis and psoriasis.肿瘤坏死因子α疗法在银屑病关节炎和银屑病中的应用。
Ann Rheum Dis. 2004 Jul;63(7):755-8. doi: 10.1136/ard.2004.020719.
4
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.银屑病和银屑病关节炎管理的护理指南:第2节。银屑病关节炎:概述及以生物制剂为重点的治疗护理指南。
J Am Acad Dermatol. 2008 May;58(5):851-64. doi: 10.1016/j.jaad.2008.02.040.
5
Superimposed linear psoriasis: low effectiveness of biologic therapy.
G Ital Dermatol Venereol. 2011 Aug;146(4):311-3.
6
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis.银屑病和银屑病关节炎生物治疗后的平均血小板体积变化
Eur J Dermatol. 2014 Jan-Feb;24(1):133-5. doi: 10.1684/ejd.2014.2269.
7
Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors.类风湿关节炎患者使用肿瘤坏死因子-α抑制剂治疗后出现脓疱型银屑病。
J Drugs Dermatol. 2008 Oct;7(10):975-7.
8
Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.依那西普单药治疗一名患有银屑病、银屑病关节炎并伴有丙型肝炎感染的患者。
J Am Acad Dermatol. 2006 Feb;54(2):361-2. doi: 10.1016/j.jaad.2005.05.043.
9
Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis.抗 TNF-α 制剂治疗银屑病和银屑病关节炎的安全性。
Immunopharmacol Immunotoxicol. 2012 Aug;34(4):548-60. doi: 10.3109/08923973.2011.653646. Epub 2012 Feb 2.
10
[Biologics in the treatment of psoriasis].[生物制剂治疗银屑病]
MMW Fortschr Med. 2006 Sep 21;148(38):42-4.

引用本文的文献

1
Role of miRNAs in the pathogenesis of psoriasis and psoriatic arthritis: a genome-wide Mendelian randomization study.微小RNA在银屑病和银屑病关节炎发病机制中的作用:一项全基因组孟德尔随机化研究
Clin Rheumatol. 2025 Apr;44(4):1607-1616. doi: 10.1007/s10067-025-07374-3. Epub 2025 Feb 22.
2
Sequencing of Targeted Therapy in Psoriasis: Does it Matter?靶向治疗药物在银屑病中的测序:这有关系吗?
Am J Clin Dermatol. 2024 Sep;25(5):795-810. doi: 10.1007/s40257-024-00874-z. Epub 2024 Jul 13.
3
Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology-Rheumatology clinic: a retrospective real-world study.
在皮肤科-风湿病联合诊所就诊的银屑病关节炎患者的患者特征、治疗模式和疾病结局:一项回顾性真实世界研究。
Rheumatol Int. 2022 Jun;42(6):1035-1041. doi: 10.1007/s00296-022-05126-z. Epub 2022 Apr 18.
4
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches.银屑病作为一种免疫介导的炎症性全身性疾病:从病理生理学到新型治疗方法
Biomedicines. 2021 Oct 21;9(11):1511. doi: 10.3390/biomedicines9111511.
5
Towards a combined pediatric rheumatology-dermatology clinic: One-year experience.迈向儿科风湿病学与皮肤病学联合门诊:一年经验
North Clin Istanb. 2020 Nov 20;8(1):37-41. doi: 10.14744/nci.2020.32848. eCollection 2021.
6
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic.多学科管理银屑病关节炎患者的临床结局和可行性:皮肤科-风湿病诊所的两年临床经验。
Clin Rheumatol. 2018 Oct;37(10):2741-2749. doi: 10.1007/s10067-018-4238-4. Epub 2018 Jul 29.
7
Which Psoriasis Patients Develop Psoriatic Arthritis?哪些银屑病患者会发展为银屑病关节炎?
Psoriasis Forum. 2010 Winter;16(4):17-25.
8
Design, synthesis and in vitro degradation of a novel co-drug for the treatment of psoriasis.新型银屑病治疗共药物的设计、合成及体外降解研究。
Pharmaceutics. 2013 Apr 17;5(2):232-45. doi: 10.3390/pharmaceutics5020232.
9
Analysis of the Potential Topical Anti-Inflammatory Activity of Averrhoa carambola L. in Mice.分析杨桃在小鼠体内的潜在局部抗炎活性。
Evid Based Complement Alternat Med. 2011;2011:908059. doi: 10.1093/ecam/neq026. Epub 2011 May 2.
10
Biological markers in the etiology of psoriasis: Targeted treatment options.银屑病病因中的生物标志物:靶向治疗选择。
Biologics. 2007 Mar;1(1):11-8.